Categories: Health

UAE approves new ReCOV clinical trial phase

(adsbygoogle = window.adsbygoogle || []).push({});

TAIZHOU, China, April 14, 2022 — Jiangsu Recbio Technology Co Ltd (Stock code:2179.HK) says the company has received approval from the Ministry of Health and Prevention of the United Arab Emirates to conduct a Phase II/III clinical study of sequential booster vaccination for its recombinant protein ReCOV.

The trial is to evaluate the immunogenicity and safety of ReCOV as a heterologous booster in adult subjects.

This clinical trial is a multi-center, randomized, observer-blinded, active-controlled phase II/III study on persons who have previously completed two doses of inactivated COVID-19 vaccine for primary vaccination and whose last vaccination is 3 to 12 months away from heterologous booster of ReCOV. It is expected that approximately 1,950 adult subjects will be enrolled.

The study’s safety and immunogenicity data are expected to be published in 2022, supporting the submission to the UAE Emergency Use Authorization (EUA) for ReCOV as a heterologous booster.

About ReCOV

In May 2020, Recbio, together with Jiangsu Provincial Center for Disease Control and Prevention (“Jiangsu CDC”) and Taizhou Medical New & High-tech Industrial Development Zone, jointly developed a recombinant two-component COVID-19 vaccine(ReCOV).

Under the guidance of Professor Fengcai Zhu from the Jiangsu CDC, the R&D team thoroughly optimized the vaccine using protein engineering and new adjuvant technologies, so that ReCOV has promising safety and strong immunogenicity against SARS-CoV-2 and variants of concern such as Omicorn and Delta.

A series of comprehensive advantages such as better cross-protection against emerging variants, easy scale-up of production, cost advantages, worldwide accessibility, good preparation stability, and storage and transportation at room temperature which become a very competitive second-generation new COVID-19 vaccine. /PRNewswire/

(adsbygoogle = window.adsbygoogle || []).push({});
(adsbygoogle = window.adsbygoogle || []).push({});


Recent Posts

A Long Week In Politics For Anwar Ends Well

A massive divide between the races in the voting patterns that have left Anwar with…

4 days ago

Anwar Is Fighting Rising Prices With Targeted Subsidies

Nevertheless, Anwar has said he plans to introduce a programme that will include targeted subsidies…

2 weeks ago

APEC: China’s Return To The Global Supply Chains

The question to ask is whether there are one too many free trade agreements around…

2 weeks ago

RCEP Came At A Good Time

After the upsets with the South China Sea disputes, we now have certain normalcy, which…

2 weeks ago

US Popularity In The Asean region

In Vietnam, the sentiments can be different because they see the Chinese encroachments in the…

3 weeks ago

New Views On Asean Plus Three and China

Asean plus three is still important for the Asean but with China's dominance, so to…

3 weeks ago